By Colin Kellaher Shares of Revelation Biosciences plunged nearly 50% in premarket trading Thursday after the life-sciences company said it is raising $6.2.
Revelation Biosciences Inc. , a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today announced the pricing of a public.